title: [FIRST-TRIMESTER ULTRASOUND AND BIOCHEMICAL MARKERS AND THEIR PREDICTIVE RATE IN PREECLAMPSIA DEVELOPMENT].
abstract: Hypertensive disorders related to pregnancy and particularly preeclampsia are leading reasons for perinatal and maternal morbidity and mortality. The symptoms of preeclampsia are occurring during the second part of pregnancy, while the pathogenic processes start developing even in first trimester. This refers to the searching for the most reliable markers, that could prove those pathological processes happened and the combination of those markers in panel for early screening in order to predict the increased risk for developing of preeclampsia. Among multiple studied markers the most promising seam to be Doppler velosimetry of uterine arteries, PIGF, sFlt-1, sEndoglin, PAPP-A, PP-13. Their combined measurement increases the predictive rate and decreases the false positive results, but is also economically irrelevant. There are researches with different medications in order to argue their preventive effect in preeclampsia developing.
authors.forename: K
authors.initials: K
authors.lastname: Chalova
authors.forename: B
authors.initials: B
authors.lastname: Pehlivanov
mesh_terms: D015415:Biomarkers / Q000032:analysis; D005260:Female; D006801:Humans; D017078:Laser-Doppler Flowmetry; D011225:Pre-Eclampsia / Q000175:diagnosis* / Q000000981:diagnostic imaging* / Q000453:epidemiology; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D012307:Risk Factors; D016216:Ultrasonography, Prenatal; D055988:Uterine Artery / Q000473:pathology
chemical_list: D015415:Biomarkers